Patent · US Active

1,2,4-oxadiazol-5-one-4-(benzimidazolylmethylamino)benzamidine compounds

US7459566B2 · kind B2 · utility

7Cited by

5References

4Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Georg Zerban · Ingelheim am Rhein, DE
Arndt Hausherr · Mainz, DE
Kerstin Schlarb · Ingelheim am Rhein, DE
Heinz-Peter Schmitt · Ingelheim am Rhein, DE
Bjoern Weyell · Aspisheim, DE
Gunter Koch · Bad Kreuznach, DE
Rainer Hamm · Ingelheim am Rhein, DE

Key dates

Filing date	Mar 2, 2007
Grant date	Dec 2, 2008
Priority date	—
Expiry date	Mar 2, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)benzamidine, the process comprising:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.